Heidi Cuthbert

Boston Scientific (NYSE:BSX) delivered a strong start to 2026, reporting first-quarter net sales of $5.203 billion.

Mastercard has joined the Blockchain Security Standards Council as a charter-level member, aiming to help shape security and privacy frameworks for blockchain networks and tokenised assets.

Blockchain.com has introduced perpetual futures trading within its non-custodial DeFi wallet, allowing users to open leveraged positions using self-custodied Bitcoin without transferring funds to an exchange.

A survey by Börse Stuttgart Digital found that 35% of European investors would consider switching banks to access better cryptocurrency services.

Coinbase and Robinhood are increasingly being valued on future product expansion, with prediction markets emerging as a central growth driver despite expected weak first-quarter trading results.

Bitget has launched a new platform called IPO Prime, allowing users to gain tokenised exposure to private companies before they go public, starting with a product linked to SpaceX.

New Zealand energy firm Mercury NZ (ASX:MCY) has raised its earnings guidance for the 2026 financial year.

Merck (NYSE:MRK), known as MSD outside the U.S. and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved IDVYNSO™, a new single-tablet antiretroviral regimen.

3M Company (NYSE:MMM) delivered a solid start to 2026, reporting adjusted earnings that exceeded Wall Street expectations and reaffirming its financial outlook for the year.

Youxin Technology (NASDAQ:YAAS) has announced the release of audited financial statements for Celnet for the fiscal years ended September 30, 2025, and 2024.